Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Edward Lifesciences pays Boston Scientific $180 million to end patent row

Edwards Lifesciences Corp. paid rival Boston Scientific Corp. $180 million as part of a settlement to end long-standing patent disputes between the two medical device makers.

Read More »

Investing Into R&D Pays off for Some of Biotech’s Biggest Companies

PwC’s annual R&D spending report showcases companies that stand out in the field of biotechnology.

Read More »

GeoVax and Enesi Pharma to Collaborate on Development of Multiple Vaccines

GeoVax Labs and Enesi Pharma announced a collaboration to develop solid-dose needle-free vaccine formulations utilizing GeoVax’s novel MVA-VLP vaccine platform in combination with Enesi’s ImplaVax device and formulation technology.

Read More »

QurAlis Spins out Med Device Company EnClear to Target ALS

EnClear Therapies – a new medical device company spun out from QurAlis – will focus developmental programs on targeting neurological diseases, including amyotrophic lateral sclerosis and progressive supranuclear palsy.

Read More »

Boston Scientific Exercises Option to Buy Millipede

Boston Scientific exercised the company’s option to buy the remaining shares of Santa Rosa, Calif.-based Millipede for $325 million.

Read More »

FDA chief to meet e-cigarette makers amid crackdown

The U.S. Food and Drug Administration plans to meet with top-level executives of e-cigarette makers, the agency’s chief said, hinting that some companies seem to be backing away from commitments related to youth’s access to e-cigarettes.

Read More »

Year-End Research Advances Approaches, Both Genetic and Device-Oriented, to Treat Obesity

A 2017 study found that more than 700 million adults and children worldwide are obese, calling it a “rising pandemic.”

Read More »

U.S. FDA approves new protocol for study on Bayer’s birth control device

The U.S. Food and Drug Administration approved a new protocol for a post-marketing study of Bayer AG’s Essure birth-control device, as the regulator seeks more information on the device’s safety.

Read More »

Why Type One Diabetes Patients Need Closed Loop Insulin Systems

For a while now there has been a heated debate surrounding hybrid and closed loop insulin systems.

Read More »

Olympus unit pleads guilty to resolve U.S. duodenoscope probe

An Olympus Corp. subsidiary pleaded guilty and agreed to pay $85 million to resolve charges of failure to file reports with U.S. regulators regarding infections connected to its duodenoscopes while continuing to sell the medical devices used to view the gastrointestinal tract.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

December 2018 Focus: Healthcare Agency Roundtable, Mobile Marketing, and more!


Ad Right Bottom